Cargando…

Outpatient Inhaled Nitric Oxide in a Patient with Vasoreactive Idiopathic Pulmonary Arterial Hypertension and COVID-19 Infection

Detalles Bibliográficos
Autores principales:	Zamanian, Roham T., Pollack, Charles V., Gentile, Michael A., Rashid, Moira, Fox, John Christian, Mahaffey, Kenneth W., de Jesus Perez, Vinicio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2020
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7328330/ https://www.ncbi.nlm.nih.gov/pubmed/32369396 http://dx.doi.org/10.1164/rccm.202004-0937LE

Ejemplares similares

Vasoreactivity to inhaled nitric oxide with oxygen predicts long-term survival in pulmonary arterial hypertension
por: Malhotra, Rajeev, et al.
Publicado: (2011)

Diagnosis and management of pulmonary hypertension associated with left ventricular diastolic dysfunction
por: Perez, Vinicio A. de Jesus, et al.
Publicado: (2012)

Clinical Characteristics and Survival of Korean Idiopathic Pulmonary Arterial Hypertension Patients Based on Vasoreactivity
por: Ahn, Jee Hwan, et al.
Publicado: (2014)

Pulmonary Vascular Capacitance as a Predictor of Vasoreactivity in Idiopathic Pulmonary Arterial Hypertension Tested by Adenosine
por: Shafie, Davood, et al.
Publicado: (2015)

Vasoreactive phenotype in children with pulmonary arterial hypertension and syncope
por: Linder, Alexandra N., et al.
Publicado: (2022)

Prognostic value of longitudinal vasoreactivity in pediatric pulmonary hypertension
por: Evers, Patrick D., et al.
Publicado: (2022)

Acute vasoreactivity testing predicts outcome of idiopathic pulmonary arterial hypertension patients with a negative acute response
por: Sun, Yuanyuan, et al.
Publicado: (2020)

EpiHope for the Treatment of Pulmonary Arterial Hypertension: Selective versus Nonselective BET Inhibition
por: Pullamsetti, Soni Savai, et al.
Publicado: (2019)

Pulmonary vasoreactivity in spontaneously hypertensive rats - Effects of endothelin-1 and leptin
por: Gomart, Samantha, et al.
Publicado: (2014)

Potential for personalised application of inhaled nitric oxide in COVID-19 pneumonia
por: Garfield, Benjamin, et al.
Publicado: (2021)

Inhaled ciclesonide for outpatients with COVID-19: A meta-analysis
por: Hsu, Chi-Kuei, et al.
Publicado: (2022)

Giant pulmonary artery aneurysm in a patient with vasoreactive pulmonary hypertension: a case report
por: Araújo, Inês, et al.
Publicado: (2011)

A case of recurrent pericardial constriction presenting with severe pulmonary hypertension
por: Brunner, Nathan W., et al.
Publicado: (2013)

Myocardial bridge: an unrecognized cause of chest pain in pulmonary arterial hypertension
por: Rajmohan, Divya, et al.
Publicado: (2020)

Clinical Study of Acute Vasoreactivity Testing in Patients with Chronic Thromboembolic Pulmonary Hypertension
por: Xu, Qi-Xia, et al.
Publicado: (2017)

Aminoglycoside inhalational therapy: a potential pitfall of antimicrobial stewardship in outpatient settings
por: Kusama, Yoshiki, et al.
Publicado: (2020)

Methamphetamine use association with pulmonary diseases: a retrospective investigation of hospital discharges in California from 2005 to 2011
por: Tsai, Halley, et al.
Publicado: (2019)

Impact of hypertension severity on arterial stiffness, cerebral vasoreactivity, and cognitive performance
por: Muela, Henrique Cotchi Simbo, et al.
Publicado: (2017)

Vasoreactive Pulmonary Arterial Hypertension Manifesting With Misleading Epileptic Seizure: Diagnostic and Treatment Pitfalls
por: Farhat, Nesrine, et al.
Publicado: (2019)

Inhaled nitric oxide minimally improves oxygenation in COVID-19 related acute respiratory distress syndrome
por: Longobardo, Alessia, et al.
Publicado: (2021)

Low-grade albuminuria in pulmonary arterial hypertension
por: Nickel, Nils P., et al.
Publicado: (2019)

Conducted Vasoreactivity: the Dynamical Point of View
por: Postnov, D. E., et al.
Publicado: (2015)

Cholesterol: A Novel Regulator of Vasoreactivity in Pulmonary Arteries
por: Grimmer, Benjamin, et al.
Publicado: (2020)

Carotid artery vasoreactivity correlates with abdominal aortic vasoreactivity in young healthy individuals but not in patients with abdominal aortic aneurysm
por: Vermeulen, Jenske J.M., et al.
Publicado: (2022)

circGSAP: A New Clinical Biomarker for Idiopathic Pulmonary Hypertension?
por: Sun, Xishi, et al.
Publicado: (2021)

Comparison of acute hemodynamic effects of inhaled nitric oxide and inhaled epoprostenol in patients with pulmonary hypertension
por: Preston, Ioana R., et al.
Publicado: (2013)

Comparison of Macitentan and Bosentan on Right Ventricular Remodeling in a Rat Model of Non-vasoreactive Pulmonary Hypertension
por: Iglarz, Marc, et al.
Publicado: (2015)

Clinical response to inhaled nitric oxide in persistent pulmonary hypertension of the newborn.
por: Ko, S. Y., et al.
Publicado: (1998)

Inhaled Nitric Oxide before Induction of Anesthesia in Patients with Pulmonary Hypertension
por: Eljezi, Vedat, et al.
Publicado: (2021)

Cerebral vasoreactivity is not impaired in patients with severe sepsis
por: Szatmári, S, et al.
Publicado: (2011)

Vasoreactivity in CADASIL: Comparison to structural MRI and neuropsychology
por: Moreton, Fiona C, et al.
Publicado: (2017)

Peripheral vasoreactivity in acute ischemic stroke with hemiplegia
por: Wang, Su Jeong, et al.
Publicado: (2021)

Endothelial nitric oxide synthase genotype is associated with pulmonary hypertension severity in left heart failure patients
por: Duarte, Julio D., et al.
Publicado: (2018)

Reply to Andréasson et al.: Multiple Manifestations of Systemic Sclerosis Affect Walk Distance
por: Zamanian, Roham T., et al.
Publicado: (2021)

Successful Treatment of a Neonate with Idiopathic Persistent Pulmonary Hypertension with Inhaled Nitric Oxide via Nasal Cannula without Mechanical Ventilation
por: Nair, Jayasree, et al.
Publicado: (2012)

Inhaled nitric oxide in patients with the acute respiratory distress syndrome secondary to the 2009 influenza A (H1N1) infection in Canada
por: Funk, Duane J., et al.
Publicado: (2012)

The Role of Neutrophils and Neutrophil Elastase in Pulmonary Arterial Hypertension
por: Taylor, Shalina, et al.
Publicado: (2018)

An electrochemical nitric oxide generator for in-home inhalation therapy in pulmonary artery hypertension
por: Liu, Yiwei, et al.
Publicado: (2022)

A Comparative Study of Inhaled Nitric Oxide and an Intravenously Administered Nitric Oxide Donor in Acute Pulmonary Hypertension
por: Stene Hurtsén, Anna, et al.
Publicado: (2020)

Pulmonary vascular effects of pulsed inhaled nitric oxide in COPD patients with pulmonary hypertension
por: Hajian, Bita, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_gtqulfchl6tehfv0ol504r4ajk